Media ReleasesCyclopharm

View All Cyclopharm News

Cyclopharm Technegas Approved in Russia

Cyclopharm Limited (ASX: CYC) is pleased to announce that it has gained regulatory approval to sell its Technegas products in Russia; furthermore, the Company has secured its first order for a
Technegas Generator and associated Patient Administration Sets.

Russia represents the 60th country globally where Technegas is now available. The order highlights  Technegas’ ongoing organic growth potential and marks a significant increase to the global
Technegas footprint.  

For more information, download the attached PDF.

Download this document

Are you a 708 sophisticated investor?

If you are a sophisticated investor as defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

We can alert you to wholesale investment opportunities not available to regular investors.

Please subscribe if you would like to be alerted to these types of opportunities.